Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 88%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,126
Total Claims
$1.4M
Drug Cost
162
Beneficiaries
$8,901
Cost/Patient
Risk Score Breakdown 11/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+178%
Opioid rate vs peers
3.6% vs 1.3% avg
+121%
Cost per patient vs peers
$8,901 vs $4,034 avg
+32%
Brand preference vs peers
12.4% vs 9.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.6%
Opioid Rate
41
Opioid Claims
$360
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 140 claims · $1.4M
Generic: 986 claims · $79K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Teriflunomide | 23 | $295K |
| Fingolimod Hcl | 19 | $202K |
| Interferon Beta-1b | 16 | $158K |
| Interferon Beta-1a | 12 | $106K |
| Ofatumumab | 11 | $86K |
| Dalfampridine | 25 | $17K |
| Erenumab-Aooe | 11 | $8,667 |
| Fingolimod Hcl | 12 | $7,920 |
| Lacosamide | 36 | $5,840 |
| Modafinil | 40 | $4,405 |
| Mycophenolate Mofetil | 22 | $3,250 |
| Pregabalin | 68 | $2,689 |
| Gabapentin | 89 | $1,830 |
| Amantadine Hcl | 11 | $1,751 |
| Ondansetron | 15 | $1,442 |
Prescribing Profile
33
Unique Drugs
11.0
Anomaly Score
Patient Profile
59
Avg Age
69%
Female
1.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About